Results 201 to 210 of about 35,480 (291)

Contributing factors for a satisfying orofacial pain patient journey: a mixed-methods study. [PDF]

J Oral Facial Pain Headache
van der Meer HA, van der Wal A, Rollman A, Lobbezoo F, Visscher CM.   +4 more
europepmc   +1 more source

Craniofacial Pain and Disability Inventory and Tampa Scale for Kinesiophobia for Temporomandibular Disorders: A Study of Responsiveness and Minimal Important Change

Journal of Oral Rehabilitation, Volume 53, Issue 4, Page 880-890, April 2026.
Graphical abstract of the manuscript published at the Journal of Oral Rehabilitation, showing the responsiveness and interpretability (Minimal Important Change [MIC]) scores for two questionnaires designed to assess patients with Temporomandibular Disorders: Craniofacial Pain and Disability Inventory (CF‐PDI) and Tampa Scale for Kinesiophobia for ...
Juliana Homem Padilha Spavieri, Mariana Romano de Lira, Aroldo dos Santos Aguiar, Thaís Cristina Chaves   +3 more
wiley   +1 more source

Chronic orofacial pain and psychological distress: findings from a multidisciplinary university clinic. [PDF]

J Oral Facial Pain Headache
Badri P, Hernández I, Long J, Amin M, Friesen R.   +4 more
europepmc   +1 more source

Daytime Sleepiness and Dispositional Optimism Are Related to Awake Bruxism Among Patients With Painful Temporomandibular Disorders

Journal of Oral Rehabilitation, Volume 53, Issue 4, Page 833-842, April 2026.
Daytime sleepiness and dispositional optimism are related with awake bruxism among patients with painful temporomandibular disorders. ABSTRACT Objective Awake bruxism (AB) is a multifactorial condition that has been linked to several physiological and psychological factors.
Bachar Reda, Frank Lobbezoo, Daniele Manfredini, Maurits K. A. van Selms   +3 more
wiley   +1 more source

TRPV1-target drugs for the treatment of orofacial pain. [PDF]

Front Pharmacol
Andrade ACM, Molina Esquivel N, Goldschmied Rossel F, Benso B.   +3 more
europepmc   +1 more source

American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel

Arthritis &Rheumatology, Volume 78, Issue 3, Page 509-522, March 2026.
Objective Vacuoles E1 enzyme X‐linked autoinflammatory somatic syndrome (VEXAS) is a recently identified rare genetic disorder associated with somatic mutations in the UBA1 gene. VEXAS presents with a combination of inflammatory and hematologic manifestations, leading to increased morbidity and mortality.
Arsene Mekinian, Sophie Georgin‐Lavialle, Marcela A. Ferrada, Sinisa Savic, Matthew J. Koster, Olivier Kosmider, Thibault Comont, Mael Heiblig, Juan I. Arostegui, Annmarie Bosco, Rim Bourguiba, Katherine R. Calvo, Catherine Cargo, Chiara Cattaneo, François Chasset, Henrique Coelho, Corrado Campochiaro, Francesca Crisafulli, Stephanie Ducharme‐Benard, Raquel Faria, Franco Franceschini, Micol Frassi, Emma M. Groarke, Carmelo Gurnari, Yervand Hakobyan, Yvan Jamilloux, Ciprian Jurcut, Yohei Kirino, Austin Kulasekararaj, Hiroyoshi Kunimoto, Lauren M. Madigan, Heřman F. Mann, Chiara Marvisi, Marcin Milchert, Sara Morais, Katja Sockel, Francesco Muratore, Hideaki Nakajima, Mrinal M. Patnaik, Luísa Regadas, Marie Robin, Abraham Rutgers, Carlo Salvarani, Anthony M. Sammel, Joerg Seebach, Pierre Sujobert, Alessandro Tomelleri, Geoffrey Urbanski, Frédéric Vandergheynst, Romana Vieira, David S. Viswanatha, Ewa Więsik‐Szewczyk, Elisa Diral, Benjamin Terrier, Bhavisha A. Patel, Pierre Fenaux, Peter C. Grayson, David B. Beck, on behalf of the International VEXAS working group, and with endorsement of EuroBloodNet, the European Reference Network in Rare Hematological Diseases, Heřman Mann, Benjamin Terrier, François Chasset, Sophie Georgin Lavialle, Alessandro Tomelleri, Campochiaro Corrado, Carlo Salvarani, Francesca Crisafulli, Franco Franceschini, Micol Frassi, Yohei Kirino, Ewa Więsik‐Szewczyk, Marcin Milchert, Raquel Faria, Ciprian Jurcut, Joerg Seebach, Sinisa Savic, David Beck, Lauren Madigan, Matthew Koster, Patnaik Mrinal, Olivier Kosmider, Pierre Sujobert, Juan I. Arostegui, Catherine Cargo, David Viswanatha, Yervand Hagopian, Mael Heilblig, Pierre Fenaux, Thibault Comont, Bruno Alessandro, Chiara Cattaneo, Elisa Diral, Sara Morais, Austin Kulasekarara, Emma Groarke, Katherine Calvo, Patel Bhavisha, Anthony Sammel, Arsene Mekinian, Benjamin Terrier, Marie Robin, Sophie Georgin Lavialle, Katja Sockel, Yvan Jamilloux, Carmelo Gurnari, Henrique Coelho, Romana Vieira, Rim Bourguiba, Marcela Ferrada, Peter Grayson   +111 more
wiley   +1 more source

Exploring salivary metabolites as biomarkers in chronic craniofacial and orofacial pain: a metabolomic analysis. [PDF]

Metabolomics
Jasinska W, Birenzweig Y, Sharav Y, Aframian DJ, Brotman Y, Haviv Y.   +5 more
europepmc   +1 more source

Pathogenesis and potential therapeutic targets of trichorhinophalangeal syndrome; lessons obtained from animal studies

Developmental Dynamics, Volume 255, Issue 3, Page 228-245, March 2026.
Abstract Trichorhinophalangeal syndrome (TRPS) is a rare genetic disease inherited in an autosomal dominant manner. It occurs in 1 in 100,000 people globally and is caused by several types of mutations of the TRPS1 gene. Since the first human patient was reported in 1966, typical and atypical pathologies, disease courses, and treatment case ...
Naoya Saeki, Rinna Kanai, Sayuri Tatsuta, Shinichi Kawaguchi, Masatsune Itoh, Shinsuke Ohba, Makoto Abe   +6 more
wiley   +1 more source

Schwann cell Lrp1 deletion drives trigeminal neuron sensitization and orofacial pain by modulating mitochondrial function and TRPV1/TRPA1 activity. [PDF]

J Headache Pain
Gong Z, Zhang M, Liu N, Asam K, Martellucci S, Aouizerat B, Campana W, Ye Y.   +7 more
europepmc   +1 more source